Attached files
file | filename |
---|---|
10-K - CardioGenics Holdings Inc. | v173825_10k.htm |
EX-31.1 - CardioGenics Holdings Inc. | v173825_ex31-1.htm |
EX-31.2 - CardioGenics Holdings Inc. | v173825_ex31-2.htm |
EX-23.2 - CardioGenics Holdings Inc. | v173825_ex23-2.htm |
EX-21.1 - CardioGenics Holdings Inc. | v173825_ex21-1.htm |
EX-10.29 - CardioGenics Holdings Inc. | v173825_ex10-29.htm |
EX-10.28 - CardioGenics Holdings Inc. | v173825_ex10-28.htm |
EX-10.30 - CardioGenics Holdings Inc. | v173825_ex10-30.htm |
EX-10.31 - CardioGenics Holdings Inc. | v173825_ex10-31.htm |
EX-32.1 - CardioGenics Holdings Inc. | v173825_ex32-1.htm |
Exhibit
23.1
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Our
report on our audit of the consolidated financial statements of CardioGenics
Holdings Inc. as of October 31, 2009 and for the year then ended and on the
statements of operations, changes in stockholders' equity (deficit) and cash
flows for the period from November 20, 1997 (date of inception) to
October 31, 2009, which expressed an unqualified opinion on those
financial statements and contains an explanatory paragraph relating to the
Company’s ability to continue as a going concern, included in this Annual Report
on Form 10-K for the year ended October 31, 2009, is dated February
12, 2010. We consent to the incorporation by reference of our report in the
following registration statement previously filed by the Company with the
Securities and Exchange Commission pursuant to the Securities Act of 1933: the
registration statement on Form S-8 with SEC file No. 333-137162.
/s/ J.H.
Cohn LLP
Roseland,
New Jersey
February
12, 2010